Skip to Content
Monday, Jul. 3, 2017, 8:00 AM
by Laura Daniel
Hypoplastic left heart syndrome (HLHS) affects one of every 4,344 newborns. It has high morbidity and mortality but little is known about the pathogenesis.
Newborns with HLHS have a severely underdeveloped left ventricle and without treatment the condition is fatal. Treatment often includes cardiac transplant; therefore, discovering the cause could allow the creation of alternative treatments.
Using whole exome sequencing, Hong reported that a nonsense mutation in NOTCH1, which results in a severe truncated Notch1 transmembrane receptor, was the likely cause of HLHS and another heart condition – hypoplastic right heart syndrome – in one family.
Notch1 controls cell fate and has been implicated in various types of structural heart disease. The findings, which suggest that HLHS is caused by a defect in the aortic outflow tract rather than ventricular morphogenesis, could eventually lead to new treatments for the condition.
The study was supported in part by National Institutes of Health grants HL104040, GM118557, HD068256 and TR000445.
Send suggestions for articles to highlight in Aliquots and any other feedback about the column to email@example.com
Health and Medicine, Reporter, Research Aliquots, Charles Hong, congenital heart disease, Department of Cell and Developmental Biology, Department of Medicine, Department of Pharmacology, gene mutation, NCATS, NHLBI, NICHD, NIGMS, NIH, pediatric cardiology, Reporter June 30 2017
There are lots of ways to keep up with Vanderbilt. Choose your preferred method: